Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
News
Pictilisib plus fulvestrant boosts PFS in ER/PR+ patients
Publish date:
December 10, 2014
AT SABCS 2014
References
msullivan@frontlinemedcom.com
Pages
« first
1
2
Recommended Reading
‘Chemo brain’ may have targetable causes
MDedge Hematology and Oncology
Breast cancer margins, radiotherapy, axillary dissection evolve
MDedge Hematology and Oncology
Meditation, yoga earn high marks as supportive care during breast cancer treatment
MDedge Hematology and Oncology
VIDEO: An easy way to improve breast biopsy practices
MDedge Hematology and Oncology
A round-up of ASCO’s 2013-2014 guideline releases, updates, and endorsements
MDedge Hematology and Oncology
Mastectomies, reconstruction, on the rise for women with early stage disease
MDedge Hematology and Oncology
Breast cancer relapse risk halved since 1986
MDedge Hematology and Oncology
Too many elderly with breast cancer still receive radiotherapy
MDedge Hematology and Oncology
SABCS 2014: Dr. Hope S. Rugo gives her top picks
MDedge Hematology and Oncology
Ultrasound screening for dense breasts is high cost, offers little benefit
MDedge Hematology and Oncology
Breast Cancer
All Specialties
